Cargando…
Management of sarcoidosis in clinical practice
Sarcoidosis is a systemic disease of unknown cause with very diverse presentation, outcome, severity and need for treatments. While some presentations may be very typical, for many patients, the presentation is nonspecific, with shared associations with other diseases at times being by far more freq...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487239/ https://www.ncbi.nlm.nih.gov/pubmed/27246591 http://dx.doi.org/10.1183/16000617.0013-2016 |
_version_ | 1784792448066650112 |
---|---|
author | Jeny, Florence Bouvry, Diane Freynet, Olivia Soussan, Michael Brauner, Michel Planes, Carole Nunes, Hilario Valeyre, Dominique |
author_facet | Jeny, Florence Bouvry, Diane Freynet, Olivia Soussan, Michael Brauner, Michel Planes, Carole Nunes, Hilario Valeyre, Dominique |
author_sort | Jeny, Florence |
collection | PubMed |
description | Sarcoidosis is a systemic disease of unknown cause with very diverse presentation, outcome, severity and need for treatments. While some presentations may be very typical, for many patients, the presentation is nonspecific, with shared associations with other diseases at times being by far more frequent or misleading, which can be a cause of significant delay and often several consultations before a diagnosis of sarcoidosis can be confirmed. This is particularly the case when pulmonary manifestations are in the forefront. The diagnosis relies on three well-known criteria. In clinical practice, these criteria are not easily implemented, particularly by physicians without expertise in sarcoidosis, which can lead to a risk of either under- or over-diagnosis. Qualifying the presentation according to sarcoidosis diagnosis is essential. However, it is often not easy to classify the presentation as typical versus compatible or compatible versus inconsistent. Further investigations are needed before any other hypothesis is to be considered. It is important to detect events and to determine whether or not they are indicative of a flare of sarcoidosis. Eventually, treatment needs to be related to the correct indications. The evaluation of the efficacy and safety of treatments is crucial. To address such issues, we present five emblematic cases that illustrate this. |
format | Online Article Text |
id | pubmed-9487239 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | European Respiratory Society |
record_format | MEDLINE/PubMed |
spelling | pubmed-94872392022-11-14 Management of sarcoidosis in clinical practice Jeny, Florence Bouvry, Diane Freynet, Olivia Soussan, Michael Brauner, Michel Planes, Carole Nunes, Hilario Valeyre, Dominique Eur Respir Rev Frontiers in Clinical Practice Sarcoidosis is a systemic disease of unknown cause with very diverse presentation, outcome, severity and need for treatments. While some presentations may be very typical, for many patients, the presentation is nonspecific, with shared associations with other diseases at times being by far more frequent or misleading, which can be a cause of significant delay and often several consultations before a diagnosis of sarcoidosis can be confirmed. This is particularly the case when pulmonary manifestations are in the forefront. The diagnosis relies on three well-known criteria. In clinical practice, these criteria are not easily implemented, particularly by physicians without expertise in sarcoidosis, which can lead to a risk of either under- or over-diagnosis. Qualifying the presentation according to sarcoidosis diagnosis is essential. However, it is often not easy to classify the presentation as typical versus compatible or compatible versus inconsistent. Further investigations are needed before any other hypothesis is to be considered. It is important to detect events and to determine whether or not they are indicative of a flare of sarcoidosis. Eventually, treatment needs to be related to the correct indications. The evaluation of the efficacy and safety of treatments is crucial. To address such issues, we present five emblematic cases that illustrate this. European Respiratory Society 2016-06 /pmc/articles/PMC9487239/ /pubmed/27246591 http://dx.doi.org/10.1183/16000617.0013-2016 Text en Copyright ©ERS 2016. https://creativecommons.org/licenses/by-nc/4.0/ERR articles are open access and distributed under the terms of the Creative Commons Attribution Non-Commercial Licence 4.0. |
spellingShingle | Frontiers in Clinical Practice Jeny, Florence Bouvry, Diane Freynet, Olivia Soussan, Michael Brauner, Michel Planes, Carole Nunes, Hilario Valeyre, Dominique Management of sarcoidosis in clinical practice |
title | Management of sarcoidosis in clinical practice |
title_full | Management of sarcoidosis in clinical practice |
title_fullStr | Management of sarcoidosis in clinical practice |
title_full_unstemmed | Management of sarcoidosis in clinical practice |
title_short | Management of sarcoidosis in clinical practice |
title_sort | management of sarcoidosis in clinical practice |
topic | Frontiers in Clinical Practice |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9487239/ https://www.ncbi.nlm.nih.gov/pubmed/27246591 http://dx.doi.org/10.1183/16000617.0013-2016 |
work_keys_str_mv | AT jenyflorence managementofsarcoidosisinclinicalpractice AT bouvrydiane managementofsarcoidosisinclinicalpractice AT freynetolivia managementofsarcoidosisinclinicalpractice AT soussanmichael managementofsarcoidosisinclinicalpractice AT braunermichel managementofsarcoidosisinclinicalpractice AT planescarole managementofsarcoidosisinclinicalpractice AT nuneshilario managementofsarcoidosisinclinicalpractice AT valeyredominique managementofsarcoidosisinclinicalpractice |